Innovation and Patent Law Reform: Hearings Before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, Ninety-eighth Congress, Second Session, on H.R. 3285, H.R. 3286, and H.R. 3605 ... March 28, April 26, and June 6, 27, 1984, 3. daļaU.S. Government Printing Office, 1985 - 2897 lappuses |
No grāmatas satura
1.–5. rezultāts no 100.
953. lappuse
... NDA Submission Date : IND Filing Date : Active Ingredient ( s ) in Approved Product : Approved Uses : Patent Claims Covering Approved Product or Use ( s ) : declares that ( s ) he is the [ title ) of the above - identified patent holder ...
... NDA Submission Date : IND Filing Date : Active Ingredient ( s ) in Approved Product : Approved Uses : Patent Claims Covering Approved Product or Use ( s ) : declares that ( s ) he is the [ title ) of the above - identified patent holder ...
992. lappuse
... NDA at the time the first ANDA is approved or could be approved . data and information may retain proprietary value in the United States and could be used by competitors to obtain product registration in foreign countries . Also , it is ...
... NDA at the time the first ANDA is approved or could be approved . data and information may retain proprietary value in the United States and could be used by competitors to obtain product registration in foreign countries . Also , it is ...
998. lappuse
... approval or disapproval runs from the initial receipt of the application . Consistent with the statutory provision for full NDAS , the period should run from the filing of the application , rather than the time of submission . There ...
... approval or disapproval runs from the initial receipt of the application . Consistent with the statutory provision for full NDAS , the period should run from the filing of the application , rather than the time of submission . There ...
1000. lappuse
... approval of paper NDAs based on the applicant's certification cf the patent status of the pioneer drug product . Althouça paper NDAS may be less attractive to generic manufacturers if a post - 1962 ANDA procedure were available , the ...
... approval of paper NDAs based on the applicant's certification cf the patent status of the pioneer drug product . Althouça paper NDAS may be less attractive to generic manufacturers if a post - 1962 ANDA procedure were available , the ...
1048. lappuse
... NDA . Those data and information may retain proprietary value in the United ... NDAs such as manufacturing methods and processes . Recommendation The draft ... approved between January 1 , 1982 and the date of enactment of the bill . It ...
... NDA . Those data and information may retain proprietary value in the United ... NDAs such as manufacturing methods and processes . Recommendation The draft ... approved between January 1 , 1982 and the date of enactment of the bill . It ...
Saturs
946 | |
954 | |
977 | |
984 | |
1019 | |
1041 | |
1134 | |
1142 | |
1435 | |
1482 | |
1577 | |
1612 | |
1656 | |
1657 | |
1660 | |
1663 | |
1145 | |
1147 | |
1183 | |
1206 | |
1207 | |
1215 | |
1221 | |
1245 | |
1284 | |
1294 | |
1307 | |
1335 | |
1341 | |
1672 | |
1680 | |
1725 | |
1739 | |
1756 | |
1786 | |
1824 | |
1835 | |
1855 | |
1867 | |
1886 | |
1888 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
1962 Amendments 2d Cir Adkins ANDA antitrust approved drug available as prior Bass benefits beta blockers bill Bolar challenge successful Circuit claims clinical testing commercial companies company/client Consent Judgment constitutional contract Corp costs decision or settlement defendant Dextrose diazepam disclosed disclosure district court DOSAGE FORM drug application drug products estoppel federal filing firms Hoffmann-La Roche I.V. Solution industry Injection innovation invalid inventor Labs Lear doctrine legislation license licensee estoppel licensor litigation manufacture monopoly NAME TRADE NAME NCEs NDAS APPROVED patent application patent infringement patent issues patent law Patent Office patent owner patent protection patent rights patent system patent term patent term restoration patent validity period pharmaceutical plaintiff preliminary injunction prior art prior invention proposed question reduced to practice regulation relief Roche royalties Sodium Sodium Chloride statutory Supp supra note Tablet tion trade secret United vaccine Zenith